RBP4, known to be an adipokine associated with hyperinsulinemia and type II diabetes in obese individuals, has previously been identified as a serum marker for multiple cancers, including breast, colorectal and ovarian cancers [11, 12]. This evidence concerns the gene RBP4 and ovarian carcinoma.